PROFOUND MEDICAL CORP. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
PROFOUND MEDICAL CORP. (PROF) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-08-06
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-06-30 was $0.00.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-03-31 was $0.00.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-09-30 was $0.00.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-06-30 was $0.00.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2025 was $0.00.
- PROFOUND MEDICAL CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was $0.00.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |